XENOTRON

LIVE

Serial Number

88125140

Owner

CURIUM US LLC

Attorney

Jeannine Rittenhouse

First Use Date

May 10, 2018

Filing Date

Sep 20, 2018

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

XENOTRON Trademark

Serial Number: 88125140 • Registration: 5761747

XENOTRON is a trademark filed by CURIUM US LLC on September 20, 2018. The trademark is classified under Class 10 (Medical Apparatus). The application is currently registered and active.

Trademark Classes

Class 10 - Medical Apparatus

Surgical, medical, dental and veterinary apparatus and instruments

Owner Contact Info

CURIUM US LLC (17 trademarks)

111 WESTPORT PLAZA
ST. LOUIS, MO 63146

Entity Type: 16

MALLINCKRODT NUCLEAR MEDICINE LLC (10 trademarks)

675 MCDONNELL BOULEVARD
HAZELWOOD, MO 63042

Entity Type: 16

Legal Representation

Attorney of Record

Jeannine Rittenhouse

1,250 trademarks filed View all →

Correspondence Address

Jeannine Rittenhouse IPHORGAN LTD.

195 ARLINGTON HEIGHTS RD

SUITE #125

BUFFALO GROVE

IL 60089-1768

Trademark Details

Filing Date

September 20, 2018

Registration Date

May 28, 2019

First Use Anywhere

May 10, 2018

First Use in Commerce

May 10, 2018

Published for Opposition

March 12, 2019

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Dec 12, 2024 NA85

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Dec 12, 2024 C15A

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Dec 10, 2024 APRE

TEAS SECTION 8 & 15 RECEIVED

Jul 2, 2024 E815

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

May 28, 2024 REM1

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Feb 26, 2020 ASGN

REGISTERED-PRINCIPAL REGISTER

May 28, 2019 R.PR

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Mar 12, 2019 NPUB

PUBLISHED FOR OPPOSITION

Mar 12, 2019 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Feb 20, 2019 NONP

ASSIGNED TO LIE

Feb 7, 2019 ALIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 23, 2019 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 16, 2019 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 15, 2019 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jan 15, 2019 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jan 7, 2019 GNRN

NON-FINAL ACTION E-MAILED

Jan 7, 2019 GNRT

NON-FINAL ACTION WRITTEN

Jan 7, 2019 CNRT

ASSIGNED TO EXAMINER

Jan 2, 2019 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 27, 2018 NWOS

Related Trademarks

More from this Owner

ONLUTREO

BEXLUTRY

More in Same Class

INTEGRATED PLATFORM SERVICES

GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,300 MG PER 130 ML (10 MG/ML)